November 21, 2026
$RichWire Markets and money, explained simply
LIVE
Fiserv Shares Climb Despite Disappointing Third-Quarter 2026 Metrics Walmart Shares Waver Despite Topping Estimates as Growth Momentum Cools Bitcoin Slips Below Key Support Level as Bearish Technical Structure Takes Hold Bitcoin Tests Support Following Drop Below $60,000 Milestone Evaluating HF Sinclair and the Turning Oil Refining Cycle Bitcoin Technical Outlook Signals Persistent Bearish Structure Despite Short-Term Bounce Mapping Out a $500 Stake in Two Emerging Quantum Computing Enterprises Bitcoin Eyes Resistance Near $61,800 Following Support Bounce Analyst Suggests Taking Profits on Global X MSCI Colombia ETF Anthropic IPO Momentum Fades as Stock Slips Below Opening Levels Bitcoin Tests Critical Monthly Support Level as Traders Watch for Breakdown or Rebound Bitcoin Tests $58,000 Put Wall Following Market Flush Fiserv Shares Climb Despite Disappointing Third-Quarter 2026 Metrics Walmart Shares Waver Despite Topping Estimates as Growth Momentum Cools Bitcoin Slips Below Key Support Level as Bearish Technical Structure Takes Hold Bitcoin Tests Support Following Drop Below $60,000 Milestone Evaluating HF Sinclair and the Turning Oil Refining Cycle Bitcoin Technical Outlook Signals Persistent Bearish Structure Despite Short-Term Bounce Mapping Out a $500 Stake in Two Emerging Quantum Computing Enterprises Bitcoin Eyes Resistance Near $61,800 Following Support Bounce Analyst Suggests Taking Profits on Global X MSCI Colombia ETF Anthropic IPO Momentum Fades as Stock Slips Below Opening Levels Bitcoin Tests Critical Monthly Support Level as Traders Watch for Breakdown or Rebound Bitcoin Tests $58,000 Put Wall Following Market Flush

Milestone Scientific Narrows Losses in Q3, Eyes Profitability

🏢 Companies 2 min read 👁 1

Milestone Scientific reported a net loss of $748,000 for the third quarter of 2026 alongside a 136% year-over-year surge in medical segment revenue, driven by expanding clinical adoption of its CompuFlo system.

Milestone Scientific Narrows Losses in Q3, Eyes Profitability🏢Companies

Photo: Motley Fool

Key points

  • Q3 net loss narrowed to $748,000 from $1.2 million a year earlier.
  • Medical segment revenue grew 136% year-over-year.
  • Management expects to approach or achieve profitability in Q4 2026.

Q3 Financials and Cost Reductions

Milestone Scientific Inc. posted total revenue of $2.2 million for the third quarter of 2026, marking a sequential adjustment following a strong second quarter. Company leadership pointed to a disciplined approach to operations that reduced operating expenses by 15.3% and improved gross margins by 280 basis points to reach 72.3%. Consequently, the quarterly net loss narrowed significantly to $748,000 compared to $1.2 million during the same period in the previous year. Management also identified roughly $400,000 in supplementary annual savings.

Medical Segment Expansion and CompuFlo Adoption

The company's commercial progress was underscored by its medical division, where revenue more than doubled year-over-year. Growth was propelled by the clinical adoption of the CompuFlo system across major domestic healthcare networks, including Rothman Orthopaedics and Pain and Spine Specialists. To capture further market share, Milestone Scientific has built a commercial network consisting of over 500 U.S. sales leads, specialized sales professionals, and distribution partnerships aimed at federal healthcare systems such as the Department of Veterans Affairs and the Department of Defense.

Outlook and International Growth

Bolstered by cost cuts and pipeline expansion, executives reaffirmed their full-year revenue guidance and expressed expectations to approach or achieve profitability in the fourth quarter of 2026. Internationally, the firm secured regulatory clearance in Turkey with broader international expansion initiatives slated for early 2027. Additionally, the company filed a provisional patent application exploring a new application for the CompuFlo technology in intrathecal pump refills.

What to watch next: Monitor whether Milestone Scientific successfully hits its fourth-quarter profitability target and tracks further adoption within major orthopedic networks.

Source Motley Fool — fool.com/earnings/call-transcripts/2026/11/13/milestone-scientific-… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.